Akums Drugs and Pharmaceuticals (BOM:544222) Total Assets : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Akums Drugs and Pharmaceuticals Total Assets?

Akums Drugs and Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2024 was ₹0 Mil.

During the past 12 months, Akums Drugs and Pharmaceuticals's average Total Assets Growth Rate was 10.60% per year. During the past 3 years, the average Total Assets Growth Rate was 15.80% per year.

During the past 4 years, Akums Drugs and Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 15.80%. The lowest was 15.80%. And the median was 15.80%.

Total Assets is connected with ROA %. Akums Drugs and Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2024 was 6.11%. Total Assets is also linked to Revenue through Asset Turnover. Akums Drugs and Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2024 was 0.24.

Akums Drugs and Pharmaceuticals Total Assets Historical Data

The historical data trend for Akums Drugs and Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akums Drugs and Pharmaceuticals Total Assets Chart

Akums Drugs and Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Total Assets

21,668.71

30,690.48

32,665.27

35,163.65

Akums Drugs and Pharmaceuticals Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial			36,046.13	-	35,163.65	42,704.03	-

Akums Drugs and Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Akums Drugs and Pharmaceuticals's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (A: Mar. 2024 )	+	Total Liabilities (A: Mar. 2024 )
	=	7204.86	+	27958.79
	=	35,164

Akums Drugs and Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	N/A	+	N/A
	=	N/A

Akums Drugs and Pharmaceuticals (BOM:544222) Total Assets Explanation

Total Assets is connected with ROA %.

Akums Drugs and Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	2607.28	/	( (42704.03	+	0)	/ 1 )
	=	2607.28	/	42704.03
	=	6.11 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Akums Drugs and Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	10104.11	/	( (42704.03	+	0)	/ 1 )
=	10104.11	/	42704.03
=	0.24

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Akums Drugs and Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Akums Drugs and Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Akums Drugs and Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akums Drugs and Pharmaceuticals Ltd (BOM:544222) » Definitions » Total Assets

Traded in Other Exchanges

AKUMS:India

Address

Akums House, Plot No. 131 to 133, Block C, Mangolpuri Industrial Area Phase1, Adjoining CBSE Office, Delhi, IND, 110083

Website

https://www.akums.in

Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).

Akums Drugs and Pharmaceuticals Headlines

No Headlines